{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:46:46Z","timestamp":1790714806263,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s11934-005-0035-0","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T18:53:34Z","timestamp":1181069614000},"page":"419-423","source":"Crossref","is-referenced-by-count":11,"title":["Urologic applications of botox"],"prefix":"10.1007","volume":"6","author":[{"given":"Courtenay","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Rackley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"35_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0302-2838(03)00250-1","volume":"44","author":"T Leippold","year":"2003","unstructured":"Leippold T, Reitz A, Schurch B: Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Urol 2003, 44:165 -174. Comprehensive literature review on the use of Botox in voiding disorders.","journal-title":"Eur Urol"},{"key":"35_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/nau.20090","volume":"24","author":"A Sahai","year":"2005","unstructured":"Sahai A, Khan M, Fowler CJ, et al.: Botulinum toxin for the treatment of lower urinary tract symptoms: a review. Neurourol Urodyn 2005, 24:2 -12. Detailed review of the literature on the application of Botox in the urinary tract.","journal-title":"Neurourol Urodyn"},{"key":"35_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ucl.2004.09.005","volume":"32","author":"TL Frenkl","year":"2005","unstructured":"Frenkl TL, Rackley RR: Injectable neuromodulatory agents: botulinum toxin therapy. Urol Clin North Am 2005, 32:89 -99. Comprehensive review of the use of Botox in urology. It includes pharmacology, indications, and injection techniques.","journal-title":"Urol Clin North Am"},{"key":"35_CR4","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B, Stohrer M, Kramer G, et al.: Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000, 164:692 -697.","journal-title":"J Urol"},{"key":"35_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"A Reitz","year":"2004","unstructured":"Reitz A, Stohrer M, Kramer G, et al.: European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004, 45:510 -515.","journal-title":"Eur Urol"},{"key":"35_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","volume":"47","author":"J Grosse","year":"2005","unstructured":"Grosse J, Kramer G, Stohrer M: Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 2005, 47:653 -659.","journal-title":"Eur Urol"},{"key":"35_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s00192-003-1099-3","volume":"14","author":"D Dykstra","year":"2003","unstructured":"Dykstra D, Enriquez A, Valley M: Treatment of overactive bladder with botulinum toxin type B: a pilot study. Int Urogynecol J Pelvic Floor Dysfunct 2003, 14:424 -426.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"35_CR8","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","volume":"63","author":"DE Rapp","year":"2004","unstructured":"Rapp DE, Lucioni A, Katz EE, et al.: Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology 2004, 63:1071 -1075.","journal-title":"Urology"},{"key":"35_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.urology.2005.01.036","volume":"66","author":"H Schulte-Baukloh","year":"2005","unstructured":"Schulte-Baukloh H, Weiss C, Stolze T, et al.: Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. Urology 2005, 66:82 -87.","journal-title":"Urology"},{"key":"35_CR10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","volume":"139","author":"DD Dykstra","year":"1988","unstructured":"Dykstra DD, Sidi AA, Scott AB, et al.: Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 1988, 139:919 -922.","journal-title":"J Urol"},{"key":"35_CR11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0022-5347(01)66376-6","volume":"155","author":"B Schurch","year":"1996","unstructured":"Schurch B, Hauri D, Rodic B, et al.: Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 1996, 155:1023 -1029.","journal-title":"J Urol"},{"key":"35_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0302-2838(02)00209-9","volume":"42","author":"M de Seze","year":"2002","unstructured":"de Seze M, Petit H, Gallien P, et al.: Botulinum A toxin and detrusor sphincter dyssynergia: a double-blind, lidocainecontrolled study in 13 patients with spinal cord disease. Eur Urol 2002, 42:56 -62.","journal-title":"Eur Urol"},{"key":"35_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0022-5347(05)66438-5","volume":"165","author":"MW Phelan","year":"2001","unstructured":"Phelan MW, Franks M, Somogyi GT, et al.: Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 2001, 165:1107 -1110.","journal-title":"J Urol"},{"key":"35_CR14","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1097\/01.ju.0000091281.50081.f0","volume":"170","author":"HC Kuo","year":"2003","unstructured":"Kuo HC: Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol 2003, 170:1908 -1912.","journal-title":"J Urol"},{"key":"35_CR15","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1097\/01.ju.0000137844.77524.97","volume":"172","author":"YC Chuang","year":"2004","unstructured":"Chuang YC, Yoshimura N, Huang CC, et al.: Intravesical botulinum toxin A administration produces analgesia against acetic acid-induced bladder pain responses in rats. J Urol 2004, 172:1529 -1532.","journal-title":"J Urol"},{"key":"35_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1159\/000020314","volume":"38","author":"D Zermann","year":"2000","unstructured":"Zermann D, Ishigooka M, Schubert J, et al.: Perisphincteric injection of botulinum toxin type A: a treatment option for patients with chronic prostatic pain? Eur Urol 2000, 38:393 -399.","journal-title":"Eur Urol"},{"key":"35_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1479-828X.2004.00163.x","volume":"44","author":"SK Jarvis","year":"2004","unstructured":"Jarvis SK, Abbott JA, Lenart MB, et al.: Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust N Z J Obstet Gynaecol 2004, 44:46 -50.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"35_CR18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","volume":"64","author":"CP Smith","year":"2004","unstructured":"Smith CP, Radziszewski P, Borkowski A, et al.: Botulinum toxin a has antinociceptive effects in treating interstitial cystitis. Urology 2004, 64:871 -875.","journal-title":"Urology"},{"key":"35_CR19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0022-5347(18)35280-7","volume":"173","author":"A Grousse","year":"2005","unstructured":"Grousse A, Gurunadha HS, Tunuguntla R, et al.: Dose-finding, prospective, randomized study to evaluate the efficacy and safety of botulinum-A toxin for refractory non-neurogenic overactive bladder. J Urol 2005, 173:305.","journal-title":"J Urol"},{"key":"35_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","volume":"174","author":"B Schurch","year":"2005","unstructured":"Schurch B, de Seze M, Denys P, et al.: Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single-treatment, randomized, placebo-controlled 6-month study. J Urol 2005, 174:196 -200. Double-blind, placebo-controlled study examining the effect of two different doses of BTX-A (200 and 300 units) in patients with neurogenic DO.","journal-title":"J Urol"},{"key":"35_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.urology.2005.02.002","volume":"66","author":"HC Kuo","year":"2005","unstructured":"Kuo HC: Clinical effects of suburothelial injection of botulinum A toxin on patients with non-neurogenic detrusor overactivity refractory to anticholinergics. Urology 2005, 66:94 -98.","journal-title":"Urology"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-005-0035-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-005-0035-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-005-0035-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-005-0035-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T11:55:26Z","timestamp":1652615726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-005-0035-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["35"],"URL":"https:\/\/doi.org\/10.1007\/s11934-005-0035-0","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}